Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatment of serious diseases with significant unmet medical needs in the orphan drug segment.

Upcoming event

Latest presentation

Latest Report

August 22, 2024

Interim report Q2 2024

Calendar and upcoming reports

October 25, 2024

Extraordinary general meeting

November 8, 2024

Interim Report Q3 2024 (7:00am CET)

Joshua’s Story

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: [email protected]